FANJ
NVO

Financial Architects (New Jersey)’s Novo Nordisk NVO Stock Holding History

Financial Architects (New Jersey)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,000
Closed -$86K – 1558
2017
Q2 		$86K Buy
+4,000
New +$80.7K 0.02% 521

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Financial Architects (New Jersey)'s NVO Position: Q2 2023 in Review

Financial Architects (New Jersey) reduced its Novo Nordisk (NVO) stake by 8.1% in Q2 2023, selling an estimated $43.3K and leaving 6,052 shares worth $490K. The position accounts for 0.07% of the portfolio, ranked #209.

Financial Architects (New Jersey) first reported a position in NVO in Q3 2013 and has held it in 34 quarters since. The position peaked at $524K in Q1 2023. 1,196 funds tracked by Wall St. Rank hold NVO as of Q2 2023.

  • Financial Architects (New Jersey) held 6,052 shares of Novo Nordisk worth $490K as of Q2 2023.
  • Financial Architects (New Jersey) sold 530 Novo Nordisk shares in Q2 2023, an estimated $43.3K.
  • Novo Nordisk made up 0.07% of Financial Architects (New Jersey)'s portfolio in Q2 2023, its #209 holding.
  • Financial Architects (New Jersey) first reported a position in Novo Nordisk in Q3 2013 and has held it in 34 quarters since.
  • Financial Architects (New Jersey)'s Novo Nordisk position peaked at $524K in Q1 2023.
  • 1,196 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2023, filed 10 Aug 2023.